Past EventMaximize Your Chances for Non-Dilutive Funding

NMBio’s March Lunch & Learn event focuses on how you can successfully secure non-dilutive funding.

The FreeMind Group’s mission is to help you win grants to fund R&D. It helps life science organizations devise and execute a long-term, multi-submission granting strategy to maximize their non-dilutive funding potential. Established in 1999, it works with both industry and academics and to date has helped its clients win over $1.5 B in awards.

Amro Eid, Director, Business Development, is our keynote presenter. Mr. Eid has experience working with different healthcare systems around the globe and has guided a successful Pricing and Market Access strategy for a novel drug in France. His passion and love for science has guided him throughout his career. During his BEng degree at City University of London, he developed a wireless acoustic sensor for the monitoring of heart and breathing sounds. Today he uses his strong background in biomedical engineering and his experience in the global health market to help non-US academic institutions secure non-dilutive funding from US sources. Mr. Amro holds a B.Eng in Biomedical Engineering from City University of London and an M.Sc. in International Health Management from Imperial College London.

Share:
Novo Norodisk

Novo Norodisk

Southwest Labs

Southwest Labs

UPS

UPS

AMRI

AMRI

Aerotek

Aerotek

Emera

Emera

Amgen

Amgen

STC UTM

STC UTM

Arrowhead Center

Arrowhead Center

New Mexico Consortium

New Mexico Consortium

Bio

Bio

Burrell College of Osteopathic Medicine

Burrell College of Osteopathic Medicine

Bristol Myers Squibb

Bristol Myers Squibb

Sandia National Laboratories

Sandia National Laboratories